510(k) device
OMNI PLUS Surgical System
Sight Sciences, Inc. · Pump, Infusion, Ophthalmic (MRH, Class II) · First FDA decision Aug 11, 2020, newest Aug 11, 2020Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
31
Naming "OMNI PLUS"
MAUDE reports
0
Brand "OMNI PLUS", since 2015
PubMed studies
1
Mentioning "OMNI PLUS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OMNI PLUS Surgical System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K201953 · Decided Aug 11, 2020 · 28 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "OMNI PLUS", any status and sponsor, newest update first.
- OMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaActive, not recruiting
Sight Sciences, Inc.Not on our public-company list
NCT06991270 · 25 participants (planned) · Start Oct 8, 2025 · Primary completion Dec 1, 2026
Device: OMNI 3.0 Surgical System · For: Primary Open Angle Glaucoma
Sites: Panama City, Panama
Universidade Cesumar (UNICESUMAR)Academic, hospital or other
NCT07859072 · 36 participants (planned) · Start Oct 2, 2026 · Primary completion Feb 5, 2027
Device: Whole-Body Neuromuscular Electrical Stimulation (WB-NMES) · For: Overweight (BMI > 25); Obesity & Overweight; Aging
Sites: Maringá, Brazil
University of British ColumbiaAcademic, hospital or other
NCT04811235 · 1 participants · Start Sep 24, 2022 · Primary completion Oct 26, 2022
Device: Near Infra-Red Spectroscopy (NIRS) Sensor · For: Acute Spinal Cord Injury; Spinal Cord Injuries
Sites: Vancouver, Canada
28 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OMNI PLUS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MRH
140 reports: 44 malfunction, 95 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "OMNI PLUS"[tiab]. The summary above synthesizes these.
- Benefit From Directional Microphone Hearing Aids: Objective and Subjective Evaluations.
Park HS, Moon IJ, Jin SH, et al. · Clin Exp Otorhinolaryngol · 2015
Other devices of this type
Also filed under product code MRH.
- OMNI Surgical SystemSight Sciences, Inc. · 510(k) 2023
- Viscoelastic InjectorSight Sciences, Inc. · 510(k) 2014
- OMNI Ultra Surgical System (1-110)Sight Sciences, Inc. · 510(k) 2026
- VIA360 Surgical SystemNew World Medical, Inc. · 510(k) 2025
- TrabEx ProMicrosurgical Technologies, Inc. · 510(k) 2022
- iPrime Viscodelivery SystemGlaukos · 510(k) 2022
- Streamline Surgical SystemNew World Medical, Inc. · 510(k) 2021
- VISCO 360 Viscosurgical SystemSight Sciences, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.